NCT01997515View on ClinicalTrials.gov

Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 26, 2019

Study Completion Date

August 22, 2019

Conditions
PainObesityHypoxia
Interventions
DRUG

Ketamine

Group K (ketamine) will receive 0.5mg /kg of ketamine bolus followed by an infusion of 0.5 mg/kg/hour of ketamine throughout the intraoperative period (Adjusted body weight).

DRUG

placebo

Group P (placebo) will receive the same amount of saline.

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01997515 - Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study | Biotech Hunter | Biotech Hunter